Jay Bharat Maruti Ltd
NSE:JAYBARMARU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jay Bharat Maruti Ltd
NSE:JAYBARMARU
|
IN |
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
US |
Balance Sheet
Balance Sheet Decomposition
Jay Bharat Maruti Ltd
Jay Bharat Maruti Ltd
Balance Sheet
Jay Bharat Maruti Ltd
| Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
13
|
12
|
3
|
9
|
4
|
14
|
22
|
8
|
13
|
19
|
24
|
23
|
9
|
15
|
22
|
33
|
0
|
24
|
17
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
23
|
9
|
15
|
22
|
33
|
0
|
4
|
4
|
|
| Cash Equivalents |
13
|
12
|
3
|
9
|
4
|
14
|
22
|
8
|
10
|
16
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
13
|
|
| Short-Term Investments |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
117
|
64
|
8
|
3
|
1
|
7
|
4
|
1
|
9
|
20
|
12
|
|
| Total Receivables |
555
|
482
|
672
|
708
|
818
|
1 184
|
848
|
549
|
449
|
398
|
1 332
|
598
|
845
|
524
|
621
|
939
|
1 442
|
1 559
|
1 135
|
|
| Accounts Receivables |
416
|
0
|
0
|
0
|
520
|
757
|
582
|
304
|
430
|
369
|
1 332
|
281
|
742
|
519
|
615
|
903
|
822
|
1 248
|
873
|
|
| Other Receivables |
139
|
482
|
672
|
708
|
298
|
427
|
266
|
245
|
19
|
29
|
0
|
317
|
103
|
5
|
6
|
36
|
620
|
311
|
262
|
|
| Inventory |
173
|
188
|
270
|
321
|
526
|
755
|
843
|
989
|
1 253
|
1 339
|
1 144
|
2 066
|
1 746
|
1 263
|
1 542
|
2 156
|
2 061
|
2 679
|
2 520
|
|
| Other Current Assets |
9
|
1
|
2
|
2
|
2
|
20
|
16
|
35
|
183
|
223
|
261
|
31
|
44
|
51
|
43
|
38
|
25
|
42
|
30
|
|
| Total Current Assets |
750
|
684
|
947
|
1 040
|
1 351
|
1 972
|
1 729
|
1 581
|
2 014
|
2 042
|
2 769
|
2 721
|
2 645
|
1 860
|
2 232
|
3 167
|
3 595
|
4 321
|
3 711
|
|
| PP&E Net |
1 383
|
1 549
|
1 904
|
2 008
|
2 588
|
3 428
|
3 741
|
3 954
|
3 953
|
4 038
|
5 098
|
7 220
|
8 810
|
9 599
|
9 428
|
9 181
|
9 024
|
10 671
|
12 291
|
|
| PP&E Gross |
1 383
|
1 549
|
1 904
|
2 008
|
0
|
3 428
|
3 741
|
3 954
|
0
|
0
|
0
|
7 220
|
8 810
|
9 599
|
9 428
|
9 181
|
9 024
|
10 671
|
12 291
|
|
| Accumulated Depreciation |
1 736
|
1 930
|
2 258
|
2 316
|
0
|
2 906
|
3 277
|
3 712
|
0
|
0
|
0
|
1 228
|
1 826
|
2 421
|
3 071
|
3 811
|
4 563
|
5 387
|
6 196
|
|
| Intangible Assets |
10
|
11
|
15
|
15
|
12
|
7
|
5
|
13
|
41
|
27
|
54
|
30
|
20
|
6
|
4
|
7
|
19
|
17
|
14
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
145
|
16
|
58
|
68
|
9
|
11
|
12
|
232
|
390
|
395
|
425
|
651
|
44
|
164
|
283
|
|
| Long-Term Investments |
24
|
23
|
24
|
24
|
24
|
24
|
24
|
23
|
123
|
84
|
116
|
151
|
170
|
208
|
243
|
264
|
271
|
343
|
376
|
|
| Other Long-Term Assets |
8
|
7
|
3
|
5
|
16
|
144
|
207
|
204
|
147
|
87
|
220
|
0
|
18
|
0
|
0
|
0
|
39
|
41
|
43
|
|
| Total Assets |
2 174
N/A
|
2 274
+5%
|
2 892
+27%
|
3 091
+7%
|
4 136
+34%
|
5 592
+35%
|
5 765
+3%
|
5 844
+1%
|
6 287
+8%
|
6 289
+0%
|
8 268
+31%
|
10 354
+25%
|
12 054
+16%
|
12 068
+0%
|
12 332
+2%
|
13 271
+8%
|
12 993
-2%
|
15 558
+20%
|
16 718
+7%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
654
|
639
|
1 033
|
1 256
|
1 216
|
1 766
|
1 400
|
1 278
|
1 603
|
1 425
|
1 836
|
1 804
|
2 048
|
1 649
|
2 060
|
2 697
|
2 570
|
3 314
|
3 159
|
|
| Accrued Liabilities |
2
|
2
|
5
|
2
|
7
|
20
|
18
|
29
|
0
|
0
|
0
|
167
|
185
|
143
|
167
|
159
|
184
|
178
|
175
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
393
|
293
|
407
|
372
|
358
|
406
|
1 170
|
518
|
794
|
1 127
|
460
|
820
|
880
|
1 128
|
1 100
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
204
|
298
|
491
|
809
|
559
|
391
|
226
|
347
|
551
|
532
|
886
|
920
|
1 036
|
1 136
|
740
|
|
| Other Current Liabilities |
91
|
86
|
181
|
180
|
395
|
275
|
313
|
363
|
509
|
549
|
333
|
1 125
|
662
|
421
|
849
|
760
|
685
|
1 070
|
911
|
|
| Total Current Liabilities |
747
|
727
|
1 220
|
1 438
|
2 215
|
2 652
|
2 628
|
2 851
|
3 029
|
2 772
|
3 565
|
3 961
|
4 241
|
3 871
|
4 421
|
5 356
|
5 356
|
6 826
|
6 086
|
|
| Long-Term Debt |
556
|
449
|
640
|
516
|
481
|
1 254
|
1 251
|
936
|
670
|
544
|
1 158
|
2 119
|
2 692
|
2 791
|
2 342
|
2 061
|
1 440
|
2 137
|
3 564
|
|
| Deferred Income Tax |
113
|
123
|
129
|
144
|
166
|
258
|
280
|
327
|
401
|
442
|
430
|
550
|
671
|
740
|
823
|
896
|
1 005
|
1 073
|
1 145
|
|
| Other Liabilities |
217
|
305
|
154
|
72
|
20
|
16
|
16
|
6
|
5
|
3
|
71
|
122
|
411
|
434
|
246
|
215
|
112
|
135
|
297
|
|
| Total Liabilities |
1 633
N/A
|
1 604
-2%
|
2 143
+34%
|
2 171
+1%
|
2 882
+33%
|
4 180
+45%
|
4 175
0%
|
4 121
-1%
|
4 105
0%
|
3 761
-8%
|
5 224
+39%
|
6 752
+29%
|
8 015
+19%
|
7 837
-2%
|
7 832
0%
|
8 528
+9%
|
7 912
-7%
|
10 171
+29%
|
11 092
+9%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
108
|
217
|
217
|
217
|
217
|
|
| Retained Earnings |
433
|
562
|
640
|
813
|
1 145
|
1 304
|
1 481
|
1 615
|
2 074
|
2 419
|
2 936
|
3 367
|
3 824
|
4 047
|
4 282
|
4 402
|
4 729
|
5 035
|
5 221
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
127
|
107
|
76
|
109
|
124
|
135
|
135
|
189
|
|
| Total Equity |
541
N/A
|
670
+24%
|
749
+12%
|
921
+23%
|
1 254
+36%
|
1 412
+13%
|
1 589
+13%
|
1 723
+8%
|
2 182
+27%
|
2 527
+16%
|
3 045
+20%
|
3 602
+18%
|
4 039
+12%
|
4 232
+5%
|
4 499
+6%
|
4 743
+5%
|
5 081
+7%
|
5 387
+6%
|
5 626
+4%
|
|
| Total Liabilities & Equity |
2 174
N/A
|
2 274
+5%
|
2 892
+27%
|
3 091
+7%
|
4 136
+34%
|
5 592
+35%
|
5 765
+3%
|
5 844
+1%
|
6 287
+8%
|
6 289
+0%
|
8 268
+31%
|
10 354
+25%
|
12 054
+16%
|
12 068
+0%
|
12 332
+2%
|
13 271
+8%
|
12 993
-2%
|
15 558
+20%
|
16 718
+7%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
43
|
108
|
108
|
108
|
|